AI in Precision Medicine Market Size, Share & Industry Analysis, By Component (Hardware/Devices and Software & Services), By Deployment (Cloud-Based, On Premise & Hybrid), By Technology (Machine Learning & Deep Learning, Natural Language Processing, & Others), By Indication (Oncology, Rare Diseases, Cardio-metabolic, Neurology, Immunology/Autoimmune, Infectious Diseases & Others), By Application (Clinical Variant Interpretation & Reporting, Therapy Selection/Clinical Decision Support, Clinical Trial Matching & Patient Stratification, & Others), By End User, and Regional Forecast, 2026-2034

Last Updated: March 18, 2026 | Format: PDF | Report ID: FBI114714

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 24.79% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Component, Deployment, Technology, Indication, Application, End User, and Region
By Component	Hardware/Devices Software & Services
By Deployment	Cloud-based On-Premise Hybrid
By Technology	Machine Learning & Deep Learning Natural Language Processing Others
By Indication	Oncology Rare diseases Cardio-metabolic Neurology Immunology/Autoimmune Infectious diseases Others
By Application	Clinical Variant Interpretation & Reporting Therapy Selection/Clinical Decision Support Clinical Trial Matching & Patient Stratification Biomarker Discovery & Target Identification Companion Diagnostics Real World Evidence & Outcomes Analytics Others
By End User	Pharmaceutical & Biotechnology Companies Healthcare Providers CROs & CDMOs Diagnostic Laboratories Others
By Region	North America (By Component, Deployment, Technology, Indication, Application, End User, and Country) U.S. Canada Europe (By Component, Deployment, Technology, Indication, Application, End User, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Component, Deployment, Technology, Indication, Application, End User, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Component, Deployment, Technology, Indication, Application, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Component, Deployment, Technology, Indication, Application, End User, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa